The molecular diagnostics market (MDx) has garnered significant attention over the last several years, particularly from analytical instrumentation manufacturers. The nascent potential for growth outside the realms of basic research, drug discovery and quality assurance/control applications are substantial. While nucleic acid amplification technologies (i.e. PCR) have been extremely valuable in both life science research and molecular diagnostics for over two decades, there has been very little success in terms of technologies being able to cross the boundaries of the other. However, it is fast becoming a reality for several key technologies from the analytical instrumentation space, moving into mainstream molecular diagnostics and posting double-digit growth over the next five years.
Molecular IVD is a sub-segment of the $50 billion in vitro diagnostics (IVD) market that embodies the analysis and detection of infectious diseases, cancer, genetic disorders, metabolic ailments, and others. The molecular IVD market is driven by the demand for faster, accurate results compared to traditional methods, advancements in technology, pharmacogenomics, therapeutic drug monitoring and personalized medicine.
The molecular IVD market provides just one part of the story. There is also a significant amount of effort within the clinical research market developing assays or tests for molecular diagnostics. During the drug development process and in clinical trials, pharmaceutical and biotechnology companies are employing companion diagnostics, where targeted drugs are being developed in association with a diagnostic test.
In this report, SDi provides market data and intelligence that characterizes the current situation, analyze trends, and present market-oriented data about the analytical solutions being used to address molecular IVD and clinical research worldwide. The analysis and data presented should have great value to executives in the molecular diagnostics market as well as the life science & analytical instrumentation industry, who are developing solutions to cater to this market.